Mortality associated with nesiritide: Letter to the Editor

American Heart Journal

Volumn 153, Issue 6, 2007, Pages

  Carroll, Richard J ^a   Mulla, Zuber D ^b   Hauck, Loran D ^c   Westbrook, Audrey ^d  

^a Adventist La Grange Memorial Hospital   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Adventist Health System   (United States)

^d FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DOBUTAMINE; NESIRITIDE;

CONGESTIVE HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL PLANNING; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; MORTALITY; POPULATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; RISK ASSESSMENT; SURVIVAL RATE;

EID: 34249279134     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.039     Document Type: Letter

References (3)

1. Arora R.R., Venkatesh P.K., and Molnar J. Short and long-term mortality with nesiritide. Am Heart J 152 (2006) 1084-1090
2. Carroll R., Mulla Z.D., Hauck L.D., et al. Nesiritide increases the odds of mortality among patients hospitalized for congestive heart failure. Am J Epidemiol 163 Suppl (2006) S1 [Abstract 001]
3. Zhang J., and Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280 (1998) 1690-1691